References
- Gordin, A.; Brooks, D. J. Clinical Pharmacology and Therapeutic Use of COMT Inhibition in Parkinson’s Disease. J. Neurol. 2007, 254 (4), IV/37–IV/48.
- Demura, N. Pharmacology and Clinical Profile of the COMT Inhibitor Entacapone as an Anti-Parkinson’s Disease Drug. Japan. Pharmacol. Therapeut. 2008, 36 (2), 155–163.
- Juri, C. C.; Chana, C. P. Levodopa for Parkinson’s Disease. What Have We Learned? Revista Medica de Chile 2006, 134 (7), 893–901.
- Najib, J. Entacapone: A Catechol-O-methyltransferase Inhibitor for the Adjunctive Treatment of Parkinson’s Disease. Clin. Therapeut. 2001, 23 (6), 802–832.
- Ragab, G. H.; Elmasry, M. S.; Kheir, A. A. Spectrophotometric Determination of Some Phenolic Drugs in Pure Form and in Their Pharmaceutical Preparations. Jordan J. Pharm. Sci. 2009, 2 (1), 66–75.
- Pagani, A. P.; Cabezon, M. A.; Ibanez, G. A. Simultaneous Kinetic-spectrofluorimetric Determination of Levodopa and Carbidopa Using Partial Least-squares Regress. Anal. Sci. 2009, 25 (5), 633–638.
- Sima, I. A.; Casoni, D.; Sarbu, C. Simultaneous Determination of Carbidopa and Levodopa Using a New TLC Method and a Free Radical as Detection Reagent. J. Liq. Chromatogr. Rel. Technol. 2013, 36 (17), 2395–2404.
- Gandhi, D. B.; Mehta, P. J. Simultaneous RP-HPTLC Method for Determination of Levodopa, Carbidopa, and Entacapone in Combined Tablet Dosage Form. J. Planar Chromatogr.--Modern TLC 2011, 24 (3), 236–241.
- Khanmohammadi, M.; Mobedi, E.; Garmarudi, A. B.; Mobedi, H.; Kargosha, K. Simultaneous Determination of Levodopa and Carbidopa in Levodopa-Carbidopa Tablets by ATR-FTIR Spectrometry. Pharm. Develop. Technol. 2007, 12 (6), 573–580.
- Talebpour, Z.; Haghgoo, S.; Shamsipur, M. 1H Nuclear Magnetic Resonance Spectroscopy Analysis for Simultaneous Determination of Levodopa, Carbidopa and Methyldopa in Human Serum and Pharmaceutical Formulations. Anal. Chim. Acta 2004, 506 (1), 97–104.
- Cesar, I. C.; Byrro, R. M. D. S. e Silva; Cardoso, F. F.; Mundim, I. M.; Souza, T. L.; Gomes, S. A.; Bonfim, R. R.; Pianetti, G. A. Development and Validation of a High-performance Liquid Chromatography-Electrospray Ionization-MS/MS Method for the Simultaneous Quantitation of Levodopa and Carbidopa in Human Plasma. J. Mass Spectr. 2011, 46 (9), 943–948.
- Zhang, L.; Chen, G.; Hu, Q.; Fang, Y. Separation and Determination of Levodopa and Carbidopa in Composite Tablets by Capillary Zone Electrophoresis with Amperometric Detection. Anal. Chim. Acta 2001, 431 (2), 287–292.
- Sravanthi, D.; Anusha, M.; Madhavi, S.; Firdose, Shaik; Nalluri, Buchi N. Simultaneous Estimation of Levodopa and Carbidopa in Bulk, Pharmaceutical Dosage Forms and Dissolution Sample Analysis by RP-HPLC-PDA Method. J. Chem. Pharm. Res. 2013, 5 (11), 422–428.
- Doshi, A. S.; Upadhyay, K. J.; Mehta, T. N.; Nanda, N. Development and Application of a High-performance Liquid Chromatographic Method for the Determination of in vitro Drug Release of Levodopa, Carbidopa, and Entacapone from a Tablet Formulation. J. AOAC Intl. 2009, 92 (2), 394–403.
- El-Bayoumi, A. E.; Badawy, A. M.; Kafou, A.; El-Ghasem, H. Determination of Levodopa in Combined Dosage Form with Carbidopa by Spectrophotometric and HPLC Methods. Bull. Faculty Pharm. (Cairo University) 2009, 47 (3), 13–20.
- Kumar, S. S.; Natraj, K.; Khan, A.; Kumar, B. K.; Rao, J. V. Development and Validation of RP-HPLC Method for Simultaneous Estimation of Levodopa and Carbidopa in Pharmaceutical Dosage Forms. J. Pharm. Res. 2011, 4 (11), 4060–4062.
- Issa, Y. M.; Hassoun, M. E. M.; Zayed, A. G. Application of High Performance Liquid Chromatographic Method for the Determination of Levodopa, Carbidopa, and Entacapone in Tablet Dosage Forms. J. Liq. Chromatogr. Rel. Technol. 2011, 34 (19), 2433–2447.
- Shalini, S.; Ravindra, R. Y. Method Development and Validation of Levodopa and Carbidopa in a Combined Dosage Form by RP-HPLC Method. Intl. J. Pharm. Technol. 2011, 3 (3), 2943–2960.
- Mao, W. Determination of Two Components in Carbidopa-levodopa Controlled-release Tablets by HPLC. Zhongguo Yaopin Biaozhun 2007, 8 (6), 74–76.
- Alagar, R. M.; Ch. Shyamsunder, D. B.; Rao, K. N. V.; Selvakumar, D. Analytical Method Development and Validation for Simultaneous Estimation of Carbidopa, Levodopa and Entacapone in Its Bulk and Tablet Dosage Form by UPLC. Intl. Res. J. Pharm. 2013, 4 (11), 53–56.
- ICH. Validation of Analytical Procedures: Text and Methodology, Q2 (R1), Geneva, Switzerland, 2005.
- ICH. Stability Testing of New Drug Substances and Products, Q1A (R2), Geneva, Switzerland, 2005.
- US FDA Guidance. Analytical Procedures and Methods Validation, Rockville, Maryland, 2000.
- Official Methods of Analysis, 15th ed.; Association of Official Analytical Chemists International: Arlington, VA, 1990; XVII p.
- Validation of Compendial Methods <1225>; The United States Pharmacopeia, 2012.
- United States Pharmacopeial Convention, 36th ed.; The United States Pharmacopoeia: Rockville, MD, 2012.
- Guideline for Submitting Samples and Analytical Data for Methods Validation; US Food and Drug Administration, February 1987, Rockville, Maryland.
- Bliesner, D. M. Validating Chromatographic Methods: A Practical Guide; John Wiley & Sons, Inc.: Hoboken, New Jersey, 2006.
- Baertschi, S. W.; Alsante, K.; Reed, R. A. Pharmaceutical Stress Testing: Predicting Drug Degradation; Informa Healthcare, London, 2005.